Valcyte (valganciclovir) - Roche, Tanabe Pharma
Prevymis (letermovir) - Merck (MSD)
Real World use of Letermovir and Valganciclovir for CMV Prophylaxis (IDWeek 2026) - Sep 6, 2026 - Abstract #P - 2060; Pres time: Oct 24, 2026; 12:15 PM - 01:30 PM; Location: Poster Hall B-C; No abstract available 
Clinical • Real-world • Real-world evidence • Infectious Disease
https://idweek2026.eventscribe.net/fsPopup.asp?PosterID=838138&mode=posterInfo
 
Cesilia Baltazar, PharmD,MBA; Amanda Lefemine, PharmD, BCIDP; Kiran Gajurel, MD; Bennett Noell, PharmD; Ethan Rausch, PharmD, BCIDP
 
Sep 6, 2026
 
Prev Next